Bio-Works Technologies: Q3 Sales Declined
Bio-Works Technologies AB reported a net sales decrease to MSEK 9.7 for the third quarter of 2026, down from MSEK 16.6 in the same period last year. The order intake remained robust.
Bio-Works Technologies AB announced its third-quarter financial results, revealing a net sales figure of MSEK 9.7 for Q3 2026. This represents a decline compared to MSEK 16.6 recorded in the third quarter of 2025, indicating a challenging period for the company.
Despite the decrease in sales, the company reported a strong order intake of MSEK 40.8 for the third quarter, an increase from MSEK 10.0 in the prior year's corresponding quarter. The order book stood at MSEK 38.1 as of September 30, 2026, suggesting sustained demand for its offerings.
For the last two quarters combined, net sales amounted to MSEK 29.7, largely flat compared to MSEK 29.8 in the preceding period. However, looking at the last four quarters, net sales reached MSEK 82.8, a significant increase from MSEK 41.4 in the prior year.
The company continues its operations with a focus on product development and market presence. Investors and analysts will be monitoring Bio-Works Technologies' ability to reverse the recent sales trend in its upcoming financial reports.